| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/14/1997 | WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | WO1997028817A1 Receptor ligand-facilitated delivery of biologically active molecules |
| 08/14/1997 | WO1997028816A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 08/14/1997 | WO1997028688A1 Intracellular vitamin d binding protein |
| 08/14/1997 | WO1997013489A3 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 08/14/1997 | DE19704979A1 Retroviral vector for expressing interleukin-6 antagonist in human haematopoietic stem cells |
| 08/14/1997 | DE19606355A1 Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung Contraceptive delivery systems with antiviral and / or antibacterial effect |
| 08/14/1997 | DE19605126A1 Thrombinmuteine als Antidot für Thrombininhibitoren Thrombin muteins as an antidote for thrombin inhibitors |
| 08/14/1997 | DE19605105A1 Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen New probe for early detection of epithelial dysplasia of the stratified squamous epithelium as well as for tumor diagnosis and tumor therapy of squamous cell carcinoma |
| 08/14/1997 | DE19604858A1 Interferon-gamma for treating or preventing amyloid precursor protein related diseases |
| 08/14/1997 | DE19604773A1 Regulierung der Spermatogenese Regulation of spermatogenesis |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2245920A1 Contraceptive release systems with antibacterial and/or antiviral effect |
| 08/14/1997 | CA2245806A1 Estrogen response element binding proteins and nucleotides encoding therefor |
| 08/14/1997 | CA2245783A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | CA2245650A1 Intracellular vitamin d binding protein |
| 08/14/1997 | CA2245546A1 Thrombin muteins as antidotes for thrombin inhibitors |
| 08/14/1997 | CA2245508A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
| 08/14/1997 | CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells |
| 08/14/1997 | CA2244792A1 Recombinant phages |
| 08/14/1997 | CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
| 08/14/1997 | CA2243718A1 Diabetes therapy |
| 08/14/1997 | CA2243707A1 Obesity protein compounds and formulations thereof |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0789076A2 G protein coupled receptor proteins, their production and use |
| 08/13/1997 | EP0788800A1 Method and kit for inducing immunological tolerance |
| 08/13/1997 | EP0788799A2 LHRH-Antagonists in the treatment of fertility disorders |
| 08/13/1997 | EP0788557A1 Rapid detection and identification of nucleic acid variants and pathogens |
| 08/13/1997 | EP0788546A1 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 08/13/1997 | EP0788545A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| 08/13/1997 | EP0788543A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 08/13/1997 | EP0788540A1 Human abh |
| 08/13/1997 | EP0788515A1 Non-antigenic branched polymer conjugates |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788512A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 08/13/1997 | EP0788511A1 Cyclic hexapeptides having antibiotic activity |
| 08/13/1997 | EP0788510A1 Dipeptide derivatives, process for producing them and medicaments containing these compounds |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788501A1 Protein kinase inhibitors for treatment of neurological disorders |
| 08/13/1997 | EP0788388A1 Device for aerosolized delivery of peptide drugs |
| 08/13/1997 | EP0788383A2 Modulation of cell proliferation and wound healing |
| 08/13/1997 | EP0788374A2 Cell-specific gene delivery vehicles |
| 08/13/1997 | EP0788371A1 Analgesic method with dynorphin analogues truncated at the n-terminus |
| 08/13/1997 | EP0788370A1 Cyclic semi-random peptide libraries |
| 08/13/1997 | EP0788368A1 Therapeutic composition for replacing and/or supplementing body fluids |
| 08/13/1997 | EP0788367A1 Stretch-activated cation channel and antisense oligonucleotides thereto |
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses |
| 08/13/1997 | EP0788354A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| 08/13/1997 | EP0788353A1 Ppar gamma antagonists for treating obesity |
| 08/13/1997 | EP0788345A1 Proteinaceous materials and formulations for sunburn cell protection |
| 08/13/1997 | EP0788307A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
| 08/13/1997 | EP0671948B1 Vaccine composition containing adjuvants |
| 08/13/1997 | EP0659175B1 Optically active alkylammonium (amino-3 phenyl)-1 ethanesulfonate derivatives, preparation and use thereof |
| 08/13/1997 | EP0658099B1 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative |
| 08/13/1997 | EP0567490B1 Non-depleting cd4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (iddm) |
| 08/13/1997 | EP0458937B1 Variants of pai-2 |
| 08/13/1997 | CN1157024A Pumping device |
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels |
| 08/13/1997 | CN1156964A Novel Peptides |
| 08/13/1997 | CN1156960A Inhalation composition |
| 08/13/1997 | CN1035616C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 08/13/1997 | CA2197408A1 Mutant human growth hormones and their uses |
| 08/13/1997 | CA2197286A1 Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs |
| 08/13/1997 | CA2197265A1 Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use |
| 08/12/1997 | US5656743 Antisense polynucleotide comprising at least one phosphorothioate linking group; antitumor agent, antiinflammatory agent |
| 08/12/1997 | US5656738 Inducible defensin peptide from mammalian epithelia |
| 08/12/1997 | US5656727 Water solubility |
| 08/12/1997 | US5656726 Antiinflammatory agents, antiarthritic agents |
| 08/12/1997 | US5656725 Stabilize inappropriate cell proliferation or cell death |
| 08/12/1997 | US5656724 Chemokine-like proteins and methods of use |
| 08/12/1997 | US5656723 Analogues of hypocalcemiant polypeptide compounds sparing the calcium of the organism, their preparation, their use as medicaments and the compositions containing them |
| 08/12/1997 | US5656722 A21 -, B30 - modified insulin derivatives having an altered action profile |
| 08/12/1997 | US5656721 Having sugar moiety; prolonged duration of action |
| 08/12/1997 | US5656667 Fatty acid composition |
| 08/12/1997 | US5656651 Androgenic directed compositions |
| 08/12/1997 | US5656650 Treating hypertension |
| 08/12/1997 | US5656645 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 08/12/1997 | US5656627 Inhibitors of interleukin-1β converting enzyme |
| 08/12/1997 | US5656612 Antisense oligonucleotide modulation of raf gene expression |
| 08/12/1997 | US5656604 Peptide compound and its preparation |
| 08/12/1997 | US5656603 Aminopeptidase P inhibitors and uses thereof |
| 08/12/1997 | US5656602 Linear or cyclic peptides of at least five residues |
| 08/12/1997 | US5656601 Acylated splenopentins, methods for their synthesis and their use |
| 08/12/1997 | US5656600 Modified polypeptides |
| 08/12/1997 | US5656599 Administering e2 trans-activation repressor fusion protein to treat papilloma virus infection |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656597 Lyospheres comprising gonadotropin |
| 08/12/1997 | US5656595 Culture product; exchange with protin p21-guanosine diphosphate complex |
| 08/12/1997 | US5656593 Morphogen induced periodontal tissue regeneration |
| 08/12/1997 | US5656592 Use of relaxin as an analgesic and palliative for intractable pain |
| 08/12/1997 | US5656591 Antimicrobial agents and method for treating products therewith |
| 08/12/1997 | US5656590 Administering amylin or derivatives to increase the amylin level of plasma of the patient |
| 08/12/1997 | US5656589 Using actin binding protein |
| 08/12/1997 | US5656588 Wound healing formula |
| 08/12/1997 | US5656587 Promotion of cell proliferation by use of transforming growth factor beta (TGF-β) |
| 08/12/1997 | US5656485 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 08/12/1997 | US5656484 Genetic engineering |